Relationship between estrogen receptor 1 gene polymorphisms and postmenopausal osteoporosis of the spine in Chinese women

被引:26
作者
Shang, D. P. [1 ]
Lian, H. Y. [1 ]
Fu, D. P. [1 ]
Wu, J. [1 ]
Hou, S. S. [1 ]
Lu, J. M. [1 ]
机构
[1] Dalian Univ, Zhongshan Hosp, Dalian, Liaoning, Peoples R China
关键词
Osteoporosis postmenopausal; Bone mineral density; Estrogen receptor 1 polymorphisms; Spine; BONE-MINERAL DENSITY; ALPHA; ASSOCIATION; BETA; MEN;
D O I
10.4238/gmr.15028106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this study was to evaluate single nucleotide polymorphism (SNP) variants of the estrogen receptor 1 gene (ESR1) at rs2234693 and rs9340799, as well as to investigate the relationship between ESR gene polymorphisms and postmenopausal osteoporosis (OP) of the spine in Chinese women. We recruited 198 postmenopausal women with OP and 276 healthy women between May 2012 and September 2015 in Zhongshan Hospital. Dual energy x-ray absorptiometry was used to measure the bone mineral density (BMD) of the lumbar vertebrae in all subjects. In addition, PCR-restriction fragment length polymorphism based analysis was conducted to identify the genotypes of ESR1. The distribution of ESR1 in the osteoporosis group and the control group was determined; the relationship between ESR polymorphisms and BMD was analyzed. The distributions of BMD were: TT < TC < CC, GG < AG < AA. The TT, TTGG, and TCGG genotypes were found to be lower as compared to the other genotypes. Stratified analysis suggested that the TT genotype and the combined genotypes TTGG and TCGG were significantly higher in the OP group as compared to the control group (P < 0.01). Therefore, ESR1 polymorphisms at rs2234693 and rs9340799 may be associated with OP, and could be used as markers to screen those with high risks to postmenopausal OP in Chinese women.
引用
收藏
页数:6
相关论文
共 19 条
[1]   Steroid hormone receptor expression and action in bone [J].
Bland, R .
CLINICAL SCIENCE, 2000, 98 (02) :217-240
[2]   Estrogen receptors α and β are differentially expressed in developing human bone [J].
Bord, S ;
Horner, A ;
Beavan, S ;
Compston, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) :2309-2314
[3]   COL1A1, ESR1, VDR and TGFB1 polymorphisms and haplotypes in relation to BMD in Spanish postmenopausal women [J].
Bustamante, M. ;
Nogues, X. ;
Enjuanes, A. ;
Elosua, R. ;
Garcia-Giralt, N. ;
Perez-Edo, L. ;
Caceres, E. ;
Carreras, R. ;
Mellibovsky, L. ;
Balcells, S. ;
Diez-Perez, A. ;
Grinberg, D. .
OSTEOPOROSIS INTERNATIONAL, 2007, 18 (02) :235-243
[4]   Estrogen receptor gene polymorphism in postmenopausal primary hyperparathyroidism [J].
Carling, T ;
Rastad, J ;
Kindmark, A ;
Lundgren, E ;
Ljunghall, S ;
Åkerström, G .
SURGERY, 1997, 122 (06) :1101-1105
[5]   Estrogen receptor gene polymorphisms and the genetics of osteoporosis:: a HuGE review [J].
Gennari, L ;
Merlotti, D ;
De Paola, V ;
Calabrò, A ;
Becherini, L ;
Martini, G ;
Nuti, R .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 161 (04) :307-320
[6]   Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo study [J].
Greendale, GA ;
Edelstein, S ;
BarrettConnor, E .
JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (11) :1833-1843
[7]   The association of bone mineral density with estrogen receptor gene polymorphisms [J].
Greendale, Gail A. ;
Jian Chu ;
Ferrell, Robert ;
Randolph, John F., Jr. ;
Johnston, Janet M. ;
Sowers, MaryFran R. .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (09) :79-86
[8]  
He JW, 2004, CHIN J ENDOCRINOL ME, V2, P140
[9]   Association of Polymorphisms of the estrogen receptor α gene with bone mineral density and fracture risk in women:: A meta-analysis [J].
Ioannidis, JPA ;
Stavrou, I ;
Trikalinos, TA ;
Zois, C ;
Brandi, ML ;
Gennari, L ;
Albagha, O ;
Ralston, SH ;
Tsatsoulis, A .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (11) :2048-2060
[10]   Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men [J].
Khosla, S ;
Melton, LJ ;
Atkinson, EJ ;
O'Fallon, WM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3555-3561